1-14 of 14
Kristine Færch
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

1613-P: Feasibility of Time-Restricted Eating in the Treatment of Type 2 Diabetes—The RESET2 Pilot Study

ANNE-DITTE TERMANNSEN, ANNEMARIE R. VARMING, GITTE S.H. STAGE HANSEN, NATASJA BJERRE, FREDERIK PERSSON, JONATAN I. BAGGER, SR., NILS B. JØRGENSEN, NANA F. HEMPLER, KRISTINE FAERCH, JONAS S. QUIST
Journal: Diabetes
Diabetes 2023;72(Supplement_1):1613-P
https://doi.org/10.2337/db23-1613-P
Published: 20 June 2023
View article titled, 1613-P: Feasibility of Time-Restricted Eating in the Treatment of Type 2 Diabetes—The RESET2 Pilot Study
Meeting Abstracts

576-P: Maintenance of Time-Restricted Eating in Daily Life to Lose Weight and Lower Risk of Type 2

NATASJA BJERRE, LOTTE HOLM, JONAS S. QUIST, KRISTINE FÆRCH, NANA F. HEMPLER
Journal: Diabetes
Diabetes 2021;70(Supplement_1):576-P
https://doi.org/10.2337/db21-576-P
Published: 01 June 2021
View article titled, 576-P: Maintenance of Time-Restricted Eating in Daily Life to Lose Weight and Lower Risk of Type 2
Meeting Abstracts

844-P: Effects of Dapagliflozin, Metformin, or Exercise on Plasma Glucagon Concentrations in Individuals with Prediabetes: The PRE-D Trial

KIM K.B. CLEMMENSEN, MARTIN B. BLOND, HANAN AMADID, LEA B. NIELSEN, DORTE VISTISEN, KRISTIAN KARSTOFT, FREDERIK PERSSON, MATHIAS RIED-LARSEN, JENS J. HOLST, NICOLAI J. WEWER ALBRECHTSEN, SIGNE S. TOREKOV, JONAS S. QUIST, MARIT E. JØRGENSEN, KRISTINE FÆRCH
Journal: Diabetes
Diabetes 2020;69(Supplement_1):844-P
https://doi.org/10.2337/db20-844-P
Published: 01 June 2020
View article titled, 844-P: Effects of Dapagliflozin, Metformin, or Exercise on Plasma Glucagon Concentrations in Individuals with Prediabetes: The PRE-D Trial
Meeting Abstracts

845-P: Changes in Plasma Levels of Liver Enzymes in Response to Dapagliflozin, Metformin, or Exercise in People with Prediabetes: The PRE-D Trial

MARTIN B. BLOND, KIM K. CLEMMENSEN, HANAN AMADID, LEA B. NIELSEN, MATHIAS RIED-LARSEN, KRISTIAN KARSTOFT, FREDERIK PERSSON, MARIT E. JØRGENSEN, KRISTINE FAERCH
Journal: Diabetes
Diabetes 2020;69(Supplement_1):845-P
https://doi.org/10.2337/db20-845-P
Published: 01 June 2020
View article titled, 845-P: Changes in Plasma Levels of Liver Enzymes in Response to Dapagliflozin, Metformin, or Exercise in People with Prediabetes: The PRE-D Trial
Meeting Abstracts

1538-P: Prevalence of Late-Evening and Nighttime Eating in Individuals with Type 2 Diabetes

JONAS S. QUIST, MARTIN B. BLOND, KRISTINE FÆRCH, BETTINA EWERS
Journal: Diabetes
Diabetes 2020;69(Supplement_1):1538-P
https://doi.org/10.2337/db20-1538-P
Published: 01 June 2020
View article titled, 1538-P: Prevalence of Late-Evening and Nighttime Eating in Individuals with Type 2 Diabetes
Meeting Abstracts

131-OR: Effects of Dapagliflozin, Metformin, or Exercise on Glucose Metabolism in Individuals with Prediabetes: The PRE-D Trial

KRISTINE FÆRCH, MARTIN B. BLOND, HANAN AMADID, LEA BRUHN NIELSEN, DORTE VISTISEN, KIM K. CLEMMENSEN, CAMILLA HARTMANN PEDERSEN, KRISTIAN KARSTOFT, MATHIAS RIED-LARSEN, MARIT E. JØRGENSEN
Journal: Diabetes
Diabetes 2019;68(Supplement_1):131-OR
https://doi.org/10.2337/db19-131-OR
Published: 01 June 2019
View article titled, 131-OR: Effects of Dapagliflozin, Metformin, or Exercise on Glucose Metabolism in Individuals with Prediabetes: The PRE-D Trial
Meeting Abstracts

901-P: Effects of Dapagliflozin, Metformin, or Exercise on Glycaemic Variability and Mean Glucose Levels in Prediabetes: The PRE-D Trial

KRISTINE FÆRCH, DORTE VISTISEN, MARTIN B. BLOND, LEA BRUHN NIELSEN, HANAN AMADID, THOMAS F. DEJGAARD, MATHIAS RIED-LARSEN, KRISTIAN KARSTOFT, FREDERIK PERSSON, MARIT E. JØRGENSEN
Journal: Diabetes
Diabetes 2019;68(Supplement_1):901-P
https://doi.org/10.2337/db19-901-P
Published: 01 June 2019
View article titled, 901-P: Effects of Dapagliflozin, Metformin, or Exercise on Glycaemic Variability and Mean Glucose Levels in Prediabetes: The PRE-D Trial
Meeting Abstracts

895-P: Effects of Dapagliflozin, Metformin, or Exercise on Markers of Cardiometabolic Risk: The PRE-D Trial

KRISTINE FÆRCH, MARTIN B. BLOND, HANAN AMADID, LEA BRUHN NIELSEN, MARIA TVERMOSEGAARD, MATHIAS RIED-LARSEN, KRISTIAN KARSTOFT, FREDERIK PERSSON, MARIT E. JØRGENSEN
Journal: Diabetes
Diabetes 2019;68(Supplement_1):895-P
https://doi.org/10.2337/db19-895-P
Published: 01 June 2019
View article titled, 895-P: Effects of Dapagliflozin, Metformin, or Exercise on Markers of Cardiometabolic Risk: The PRE-D Trial
Meeting Abstracts

905-P: Safety, Adherence, and Treatment Satisfaction with Dapagliflozin, Metformin, or Exercise in Individuals with Prediabetes: The Pre-D Trial

HANAN AMADID, MARTIN B. BLOND, LEA BRUHN, KIM K. CLEMMENSEN, CAMILLA T. VAINØ, FREDERIK PERSSON, MARIT E. JØRGENSEN, KRISTINE FÆRCH
Journal: Diabetes
Diabetes 2019;68(Supplement_1):905-P
https://doi.org/10.2337/db19-905-P
Published: 01 June 2019
View article titled, 905-P: Safety, Adherence, and Treatment Satisfaction with Dapagliflozin, Metformin, or Exercise in Individuals with Prediabetes: The Pre-D Trial
Journal Articles

Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation

Kristine Færch, Dorte Vistisen, Giovanni Pacini, Signe S. Torekov, Nanna B. Johansen, Daniel R. Witte, Anna Jonsson, Oluf Pedersen, Torben Hansen, Torsten Lauritzen, Marit E. Jørgensen, Bo Ahrén, Jens Juul Holst
Journal: Diabetes
Diabetes 2016;65(11):3473–3481
https://doi.org/10.2337/db16-0240
Published: 08 August 2016
View article titled, Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation
Open the PDF for Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation in another window
Journal Articles

Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci

Geoffrey A. Walford, Stefan Gustafsson, Denis Rybin, Alena Stančáková, Han Chen, Ching-Ti Liu, Jaeyoung Hong, Richard A. Jensen, Ken Rice, Andrew P. Morris, Reedik Mägi, Anke Tönjes, Inga Prokopenko, Marcus E. Kleber, Graciela Delgado, Günther Silbernagel, Anne U. Jackson, Emil V. Appel, Niels Grarup, Joshua P. Lewis, May E. Montasser, Claes Landenvall, Harald Staiger, Jian’an Luan, Timothy M. Frayling, Michael N. Weedon, Weijia Xie, Sonsoles Morcillo, María Teresa Martínez-Larrad, Mary L. Biggs, Yii-Der Ida Chen, Arturo Corbaton-Anchuelo, Kristine Færch, Juan Miguel Gómez-Zumaquero, Mark O. Goodarzi, Jorge R. Kizer, Heikki A. Koistinen, Aaron Leong, Lars Lind, Cecilia Lindgren, Fausto Machicao, Alisa K. Manning, Gracia María Martín-Núñez, Gemma Rojo-Martínez, Jerome I. Rotter, David S. Siscovick, Joseph M. Zmuda, Zhongyang Zhang, Manuel Serrano-Rios, Ulf Smith, Federico Soriguer, Torben Hansen, Torben J. Jørgensen, Allan Linnenberg, Oluf Pedersen, Mark Walker, Claudia Langenberg, Robert A. Scott, Nicholas J. Wareham, Andreas Fritsche, Hans-Ulrich Häring, Norbert Stefan, Leif Groop, Jeff R. O’Connell, Michael Boehnke, Richard N. Bergman, Francis S. Collins, Karen L. Mohlke, Jaakko Tuomilehto, Winfried März, Peter Kovacs, Michael Stumvoll, Bruce M. Psaty, Johanna Kuusisto, Markku Laakso, James B. Meigs, Josée Dupuis, Erik Ingelsson, Jose C. Florez
Journal: Diabetes
Diabetes 2016;65(10):3200–3211
https://doi.org/10.2337/db16-0199
Published: 14 July 2016
View article titled, Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies <em>BCL2</em> and <em>FAM19A2</em> as Novel Insulin Sensitivity Loci
Open the PDF for Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies <em>BCL2</em> and <em>FAM19A2</em> as Novel Insulin Sensitivity Loci in another window
Includes: Supplementary data
Journal Articles

Response to Comment on Færch et al. GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study. Diabetes 2015;64:2513–2525

Kristine Færch, Signe S. Torekov, Dorte Vistisen, Nanna B. Johansen, Daniel R. Witte, Anna Jonsson, Oluf Pedersen, Torben Hansen, Torsten Lauritzen, Annelli Sandbæk, Jens Juul Holst, Marit E. Jørgensen
Journal: Diabetes
Diabetes 2015;64(9):e30–e31
https://doi.org/10.2337/db15-0743
Published: 13 August 2015
View article titled, Response to Comment on Færch et al. GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study. Diabetes 2015;64:2513–2525
Open the PDF for Response to Comment on Færch et al. GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study. Diabetes 2015;64:2513–2525 in another window
Journal Articles

GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study

Kristine Færch, Signe S. Torekov, Dorte Vistisen, Nanna B. Johansen, Daniel R. Witte, Anna Jonsson, Oluf Pedersen, Torben Hansen, Torsten Lauritzen, Annelli Sandbæk, Jens Juul Holst, Marit E. Jørgensen
Journal: Diabetes
Diabetes 2015;64(7):2513–2525
https://doi.org/10.2337/db14-1751
Published: 12 February 2015
View article titled, GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study
Open the PDF for GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study in another window
Includes: Supplementary data
Journal Articles

G-allele of Intronic rs10830963 in MTNR1B Confers Increased Risk of Impaired Fasting Glycemia and Type 2 Diabetes Through an Impaired Glucose-Stimulated Insulin Release: Studies Involving 19,605 Europeans

Thomas Sparsø, Amélie Bonnefond, Ehm Andersson, Nabila Bouatia-Naji, Johan Holmkvist, Lise Wegner, Niels Grarup, Anette P. Gjesing, Karina Banasik, Christine Cavalcanti-Proença, Marion Marchand, Martine Vaxillaire, Guillaume Charpentier, Marjo-Riitta Jarvelin, Jean Tichet, Beverley Balkau, Michel Marre, Claire Lévy-Marchal, Kristine Færch, Knut Borch-Johnsen, Torben Jørgensen, Sten Madsbad, Pernille Poulsen, Allan Vaag, Christian Dina, Torben Hansen, Oluf Pedersen, Philippe Froguel
Journal: Diabetes
Diabetes 2009;58(6):1450–1456
https://doi.org/10.2337/db08-1660
Published: 26 March 2009
View article titled, G-allele of Intronic rs10830963 in <em>MTNR1B</em> Confers Increased Risk of Impaired Fasting Glycemia and Type 2 Diabetes Through an Impaired Glucose-Stimulated Insulin Release: <subtitle>Studies Involving 19,605 Europeans</subtitle>
Open the PDF for G-allele of Intronic rs10830963 in <em>MTNR1B</em> Confers Increased Risk of Impaired Fasting Glycemia and Type 2 Diabetes Through an Impaired Glucose-Stimulated Insulin Release: <subtitle>Studies Involving 19,605 Europeans</subtitle> in another window
Includes: Supplementary data